Send feedback

ALG3 p.Ile107Val

c.319A>G · rs2233463 · VCV344358

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
AlphaMissense
likely benign
0.0848 · ACMG-weighted
gnomAD v4.1
Rare
low-frequency (popmax 2.28%, mid)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
ALG3-congenital disorder of glycosylation

Computational evidence

Protein change
AlphaMissense0.0848likely benign
REVEL0.191benign-leaning
SaProtLLR -6.92tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.2GERP 0.39, phastCons 1
Regional constrainto/e 1.09unconstrained · MANE · 3,742 bp · p 0.14 · regional, not allelic
Overall
CADD16.47PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 2.28% Middle Eastern · 138/6,060 alleles
Filtering AF 1.97% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.94%
Overall 1.69% 27,234/1,613,360 alleles · low-frequency
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 3.48% 29
Amishnot grpmax-eligible 2.63% 38
Middle Easterngrpmax 2.28% 44
European (non-Finnish) 1.97% 51
Remaining individualsnot grpmax-eligible 1.69% 59
Admixed American 0.962% 104
South Asian 0.94% 106
African / African-American 0.315% 318
Finnishnot grpmax-eligible 0.106% 941
East Asian 0.00446% 22,436

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ALG3
Protein
p.Ile107Val
Coding
c.319A>G
MANE Select
NM_005787
dbSNP
rs2233463
Type
single nucleotide variant
Location
chr3:184245593 (GRCh38)
Gene constraint
LOEUF 0.972 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 89.05
Residue 107
a UniProt-annotated variant site (in)
Full ALG3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

ALG3-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For ALG3-CDG (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alg3-p-ile107val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown